Medacta Group SA Reports Notable Revenue Growth in H1 2026

Medacta Group SA announced a 9.7% increase in revenue growth in constant currency for the first half of 2026, reaching a total of €368 million. This growth surpassed market expectations across all geographical areas and business lines.

The company attributes its success to continuous innovation and an expanded sales force focusing on medical education. New surgery techniques and technologies, such as the Augmented Reality (AR) navigation system, played a key role in driving revenue, particularly in the hip and knee segments.

Geographically, the Asia Pacific and EMEA regions contributed significantly, with growth rates of 13.1% and 10.0% respectively. In the U.S., Medacta faced challenges with existing customers in joints, yet revenue from new surgeon activities improved.

Medacta is also optimizing its supply chain with a new automated warehouse in Italy and expansion projects in Switzerland and the U.S., marking a strategic effort to strengthen its global presence.